Overview

Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers

Status:
Completed

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

Summary

PET (positron emission tomography) imaging with BAY85-8101 for investigation in patients with Multiple Sclerosis compared to healthy volunteers

Phase:

Phase 1

Details

Lead Sponsor:

Bayer